[1] KOH DM,SCURR E,COLLINS DJ,et al.Colorectal hepatic metastases:quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging[J].Eur Rad,2006,16(9):1898.
[2] SOURBRON SP,BUCKLEY DL.On the Scope and Interpretation of the Tofts Models for DCE-MRI[J].Magn Reson Med,2011,66(3):735.
[3] MIYAZAKI K,COLLINS DJ,WALKER-SAMUEL S,et al.Quantitative mapping of hepatic perfusion index using MR imaging:a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120,a potent triple angiokinase inhibitor[J].Eur Rad,2008,18(7):1414.
[4] 李静.血管内皮生长因子与血液肿瘤的相关性研究[J].蚌埠医学院学报,2012,37(3):364.
[5] 仵志远,姜德清,郝占伟.CD147和基质金属蛋白酶-9在肝细胞肝癌中的表达与微血管生成的相关性[J].蚌埠医学院学报,2015,40(4):450.
[6] 王化,王伟,唐光健.肝细胞癌影像学诊断的现状与进展[J].中华放射学杂志,2006,40(3):315.
[7]
[8] JIANG H,LU H,ZHANG Z,et al.Experimental study on angiogenesis in a rabbit VX2 early liver tumour by perfusion computed tomography[J].J Intern Med Res,2010,38(3):929.
[9] YUN TJ,PARK CK,KIM TM,et al.Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy:differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging[J].Radiology,2015,274(3):830.
[10] 李金平,姜慧杰.多层螺旋CT灌注参数对肝癌血流变化的诊断价值[J].中国医学计算机成像杂志,2011,17(4):377.
[11] CHIKUI T,KITAMOTO E,KAWANO S,et al.Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer[J].J Magn Reson Imaging,2012,36(3):589.
[12] KIM JH,KIM CK,PARK BK,et al.Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy[J].Eur Rad,2012,22(11):2533.
[13] SAHANI DV,JIANG T,HAYANO K,et al.Magnetic resonance imaging biomarkers in hepatocellular carcinoma:association with response and circulating biomarkers after sunitinib therapy[J].J Hematol Oncol,2013,6:51.